Merck news

Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst

Merck & Co., Inc. Receives CHMP Positive Opinion For New Fertility Treatment, ELONVA

Reuters Key Development - 58 minutes ago

WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc.

Glaxo, Merck developing drugs for kala azar

DNA India - 23 minutes ago
Heard of kala azar or leishmaniasis? Chances are you haven't. Amid cancer, diabetes, strokes, flu, arthritis, etc, this life threatening disease, which affects millions of poor people in the world ...

Notable 52-Week NYSE New Highs and Lows 11/19: CAH, DCI, RX, KG, MRK, TSL Highs; SNV, WNR Low

NEWS | SAN DIEGO Ligand earns $2 million in milestone payments from Merck

San Diego Daily Transcript - 1 hour ago
Ligand Pharmaceuticals Inc. (Nasdaq: LGND) has received $2 million in milestone payments from NV Organon, a subsidiary of Merck & Co. Inc. (NYSE: MRK), stemming from its research collaboration ...

LGND: Receives $2M Milestone Payment from Merck's NV Organon

Trading Markets - 56 minutes ago
Ligand Pharmaceuticals Incorporated (LGND) has received $2 million in milestone payments from NV Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to ...

Incorporated - Ligand Earns $2 Million in Milestone Payments from Merck & Co., Inc.

Applied Materials, Merck and Braunschweig University awarded funding

CORRECT:In Overhaul,Drug Industry Insider Sees 'Good, Bad, Ugly'

Wall Street Journal - 3 minutes ago
("In Overhaul, Drug Industry Insider Sees 'Good, Bad And Ugly'," published at 12:26 pm EST Wednesday, incorrectly described the position of Merck executive Jane Horvath in the second paragraph. A ...